Patents Assigned to Zeneca
  • Patent number: 6184392
    Abstract: 3-Isochromanome is prepared by reacting an o-xylene-&agr;,&agr;′-dihalide with carbon monoxide and water in the presence of a metal catalyst such that the pH of the reaction is maintained between about 7 and 11.
    Type: Grant
    Filed: December 8, 1999
    Date of Patent: February 6, 2001
    Assignee: Zeneca Limited
    Inventors: Hannah Sallie Robertson McCann, Raymond Vincent Heavon Jones
  • Patent number: 6184225
    Abstract: The invention relates to quinazoline derivatives of formula (I) wherein: Z represents —O—, —NH— or —S—; m is an integer from 1 to 5; R1 represents hydrogen, hydroxy, halogeno, nitro, trifluorometlyl, cyano, C1-3alkyl, C1-3alkoxy, C1-3alkylthio or NR5R6 (wherein R5 and R6, which may be the same or different, each represents hydrogen or C1-3alkyl); R2 represents hydrogen, hydroxy, halogeno, methoxy, amino, or nitro; R3 represents hydroxy, halogeno, C1-3alkyl, C1-3alkoxy, C1-3alkanoyloxy, trifluoromethyl, cyano, amino or nitro; X1 represents —O—, —CH2—, —S—, —SO—, SO2—, —NR6—, NR8CO—, —CONR9—SO2NR10— or —NR11SO2—, (wherein R7, R8, R9, R10 and R11 each represents C1-3alkyl, C1-3alkoxyC2-3alkyl); R4 represents a group which is alkenyl, alkynyl or optionally substituted alkyl, which alkyl group may contain a heteroatom linking group, which alkenyl, alkynyl or al
    Type: Grant
    Filed: August 13, 1998
    Date of Patent: February 6, 2001
    Assignee: Zeneca Limited
    Inventors: Andrew Peter Thomas, Craig Johnstone, Laurent Francois Andre Hennequin
  • Patent number: 6184207
    Abstract: The invention concerns pharmacologically useful peptide derivatives of the formula (I): P-AA1-AA2-AA3-AA4-AA5-AA6-AA7-AA8-Q, and pharmaceutically acceptable salts thereof, wherein either AA3 together with AA4, or AA4 together with AA5, or AA6 together with AA7 form a group of formula (II): in which Ra is selected from hydrogen and (1-4C)alkyl, and the remainder of AA1, AA2, AA3, AA4, AA5, AA6, AA7, and AA8 are L-amino acid residues; P is a hydrophobic residue; and Q is OH, NH2 or NRcRd. The invention further concerns processes for the manufacture of the novel peptide derivatives and the use of the compounds, and pharmaceutical compositions containing them, in treating MHC class II dependent T-cell mediated autoimmllne or inflammatory diseases, such as rheumatoid arthritis.
    Type: Grant
    Filed: June 14, 1999
    Date of Patent: February 6, 2001
    Assignee: Zeneca Limited
    Inventors: Richard William Arthur Luke, Ronald Cotton
  • Patent number: 6180376
    Abstract: Oil is extracted from oil containing microorganisms by disintegrating the microorganisms and contacting them in the presence of a water content of at least 70% by weight of that originally present in the cellular material with a water immiscible solvent for the oil, separating the solvent from the microorganisms and recovering the oil from the solvent.
    Type: Grant
    Filed: January 20, 1998
    Date of Patent: January 30, 2001
    Assignee: Zeneca Limited
    Inventor: John Macdonald Liddell
  • Patent number: 6177442
    Abstract: The invention provides a compound of formula (I): wherein A represents a bidentate group of formula —CH2—X—CH2— (wherein X is methylene, sulfur or oxygen), X′C═CY or X′WC—CYZ (wherein X′, W, Y and Z are independently hydrogen, hydroxy, acyloxy, alkoxy, alkylsilyloxy, cyano or halogen, or X′ and W or Y and Z together with the carbon to which they are attached form a carbonyl group), provided that A is not CH2—CH2; Ar is an optionally substituted phenyl or 5- or 6-membered heterocyclic ring system containing from 1 to 3 heteroatoms individually selected from nitrogen, oxygen and sulfur atoms, and at least one unsaturation (double bond) between adjacent atoms in the ring, said heterocyclic ring being optionally fused to a benzene ring; aryl, heteroaryl, aralkyl, heteroarylalkyl, alkenyl, aralkenyl, alkynyl, alkoxycarbonyl, alkanesulfonyl, arenesulfonyl, alkanyloxycarbonyl, aralkyloxycarbonyl, aryloxycarbonyl, heterocyclylalkyl, ca
    Type: Grant
    Filed: July 21, 1999
    Date of Patent: January 23, 2001
    Assignee: Zeneca Limited
    Inventors: Christopher John Urch, Terence Lewis, Raymond Leo Sunley, Roger Salmon, Christopher Richard Ayles Godfrey, Christopher Ian Brightwell, Matthew Brian Hotson
  • Patent number: 6174894
    Abstract: The present invention provides a compound of Formula (I): wherein Ar is optionally substituted phenyl wherein the substutuents, if present, are selected from halogen atoms, cyano, alkyl, alkenyl, alkynyl, alkoxy, haloalkyl, haloalkenyl, alkylthio and alkyl amino groups; R represents hydrogen or cyano or a group selected from alkyl, aryl, heteroaryl, aralkyl, heteroarylalkyl, alkenyl, aralkenyl, alkynyl, alkoxycarbonyl, alkanesulfonyl, arenesulfonyl, alkenyloxycarbonyl, aralkyloxycarbonyl, aryloxycarbonyl, heterocyclylalkyl, carbamyl, dithiocarboxyl or XR3 (where X represents oxygen or a group NR4); R3 and R4 are, independently, hydrogen, alkyl, aryl, heteroaryl, aralkyl, heteroarylalkyl, alkenyl, aralkenyl, alkynyl, heterocyclylalkyl, alkoxycarbonyl or carboxylic acyl each of which may be optionally substituted; R1 represents hydrogen, hydroxy, alkyl, alkoxy, amino, nitro, isocyanato, acylamino, hydroxyalkyl, optionally substituted heteroaryl, alkoxyalkyl, haloalkyl, halohydroxyalkyl, aralky
    Type: Grant
    Filed: July 21, 1999
    Date of Patent: January 16, 2001
    Assignee: Zeneca Limited
    Inventors: Christopher John Urch, Terence Lewis, Raymond Leo Sunley, Roger Salmon, Christopher Richard Ayles Godfrey, Christopher Ian Brightwell
  • Patent number: 6172279
    Abstract: Male sterility is imparted to a plant by a cascade of gene sequences which expresses a protein which disrupts the biosynthesis of viable pollen. Expression of the disrupter protein is restricted to male parts of the plant by an upstream promoter sequence which is specific to male flowers, the male specific promoter being under control of an operator sequence. The cascade also includes a gene encoding a repressor protein specific for that operator. Expression of the repressor protein is under control of a chemically inducible promoter which is inducible by the application to the plant by, spraying or like process, of an exogenous chemical. In the absence of the exogenous chemical inducer, no repressor protein is expressed, resulting in expression of the disrupter protein and, consequently, male sterility.
    Type: Grant
    Filed: November 7, 1995
    Date of Patent: January 9, 2001
    Assignee: Zeneca Limited
    Inventors: Ian George Bridges, Simon William Jonathan Bright, Andrew James Greenland, Wolfgang Walter Schuch
  • Patent number: 6169101
    Abstract: A fungicidal compound having general formula (I) or a stereoisomer thereof, wherein A is CH or N, B is OCH3 or NHCH3, R1 is H, chloro or methyl and R2 is H, fluoro, chloro or methyl.
    Type: Grant
    Filed: June 18, 1998
    Date of Patent: January 2, 2001
    Assignee: Zeneca Limited
    Inventor: Paul John De Fraine
  • Patent number: 6165777
    Abstract: A process for resolution of a mixture of dihydroxydihydroindene enantiomers comprising treating the mixture of enantiomers with a Pseudomonas putida species microorganism.Resolved dihydroxydihydroindenes are valuable intermediates for the synthesis of biologically active compounds such as pharmaceuticals and agrochemicals.
    Type: Grant
    Filed: June 9, 1998
    Date of Patent: December 26, 2000
    Assignee: Zeneca Limited
    Inventors: Christopher Curtis Royston Allen, Derek Raymond Boyd, Howard Dalton
  • Patent number: 6162916
    Abstract: A process for preparing agrochemical intermediates of formula (I), wherein W is (CH.sub.3 O).sub.2 CH.CHCO.sub.2 CH.sub.3 or CH.sub.3 O.CH.dbd.CCO.sub.2 CH.sub.3 ; Z.sup.1 is a halogen atom; and R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are independently hydrogen, halogen, C.sub.1-4 alky, C alkoxy, acetoxy or acyl; the process comprising the steps of: (a) reacting a compound of formula (II), wherein X, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined above, with a compound of formula ROCH.sub.3, wherein R is a metal; and, (b) reacting the product of (a) with a compound of formula (III), wherein Z.sup.1 and Z.sup.2 are halogen atoms. A process for the preparation of compounds of formula (II) and compounds of formula (II) themselves. A process for obtaining, in substantially pure form, a compound of formula (11) and compounds of formula (II) themselves. A process for obtaining, in substantially pure form, a compound of formula (11) wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are all hydrogen.
    Type: Grant
    Filed: February 16, 1999
    Date of Patent: December 19, 2000
    Assignee: Zeneca Limited
    Inventors: Alan John Whitton, Brian Geoffrey Cox, Gareth Andrew De Boos, Ian Gordon Berry, Ian George Fleming, Raymond Vincent Heavon Jones
  • Patent number: 6160123
    Abstract: The present invention provides an improved process for preparing (S)-4-{[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl}-2-oxazolidinone which comprises: a) forming a carbamate of formula (III), from methyl 4-nitro-(L)-phenylalaninate hydrochloride; b) reducing the compound of formula (III) to give the compound of formula (IV); c) reducing the methyl ester grouping in the compound of formula (IV) to give the compound of formula (V); d) ring closure of the compound of formula (V) to give the compound of formula (VI); e) diazonium salt formation from the compound of formula (VI) followed by reduction to give the compound of formula (VII); f) Fischer reaction of the compound of formula (VIl) to give (S)-4-{[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl}-2-oxazolidinone.
    Type: Grant
    Filed: February 2, 2000
    Date of Patent: December 12, 2000
    Assignee: Zeneca, Ltd.
    Inventor: Rajnikant Patel
  • Patent number: 6160117
    Abstract: 4,6-Dichloropyrimidine is prepared by treating 4,6-dihydroxypyrimidine with a chlorinating agent of the formula R.sup.1 R.sup.2 R.sup.3 PCl.sub.2 wherein R.sup.1, R.sup.2 and R.sup.3 are independently alkyl or aryl, or one or more of the groups R.sup.1, R.sup.2 and R.sup.3 is linked to a polymer support. Conveniently, the chlorinating agent may be prepared in situ by reacting the corresponding phosphine oxide with phosgene. Thus, in a preferred process, 4,6-dichloropyrimidine is prepared by treating 4,6-dihydroxypyrimidine with phosgene in the presence of a phosphine oxide.
    Type: Grant
    Filed: November 5, 1998
    Date of Patent: December 12, 2000
    Assignee: Zeneca Limited
    Inventors: Alan John Whitton, Ewan Campbell Boyd, Michael Charles Henry Standen, Peter Karl Wehrenberg, Raymond Vincent Heavon Jones, Timothy John Doyle, David Alan Glanville
  • Patent number: 6156904
    Abstract: 5-Chloro-2-(4,4-difluorobutylthio)thiazole is prepared from 2-mercaptotriazole by a multistep process involving S-alkylation, chlorination and dehydrochlorination and is converted by oxidation to the corresponding sulfone which is useful as an agricultural nematicide.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: December 5, 2000
    Assignee: Zeneca Limited
    Inventors: Martin Charles Bowden, Stephen Martin Brown
  • Patent number: 6153750
    Abstract: A process for preparing (E)-methyl 2-[2-(6-(-cyanophenoxy)pyrimidin-4-yloxy)phenyl]-3-methoxypropenoate comprising contacting (E)-methyl 2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3-methoxypropenoate or methyl 2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3,3-dimethoxypropanoate with 2-cyanophenate anions, the process being conducted in the absence of copper or a copper salt and in the absence of N,N-dimethylformamide. The 2-cyanophenate anions are generated in situ by reacting 2-cyanophenol with an alkali metal carbonate.
    Type: Grant
    Filed: June 10, 1999
    Date of Patent: November 28, 2000
    Assignee: ZENECA Limited
    Inventors: Alan John Whitton, Ian George Fleming, Robert Comgall Ewins, Raymond Vincent Heavon Jones, Samuel McNeish
  • Patent number: 6150586
    Abstract: The capacity of a plant to produce fatty acids is modulated by controlling the expression of a gene specifying the acetyl CoA carboxylase biotin carboxyl carrier protein. Modulation may comprise increasing the expression of the gene by insertion of additional copies into the genome or inhibiting expression by insertion of an antisense or cosuppression vector directed against the endogenous gene.
    Type: Grant
    Filed: January 20, 1998
    Date of Patent: November 21, 2000
    Assignee: Zeneca Limited
    Inventors: Antoni Ryszard Slabas, Kieran Michael Elborough
  • Patent number: 6149722
    Abstract: Phthalocyanine compounds of Formula (1) have utility as colorants in inks for ink-jet printing, where Formula (1) represents: ##STR1## in which: M represents a metal or H;Pc represents a phthalocyanine nucleus; andR.sup.1 represents H or --(CH.sub.2).sub.n R.sup.3 ; R.sup.2 represents(CH.sub.2).sub.n R.sup.3 ; or R.sup.1 and R.sup.2 together with the nitrogen atom to which they are attached represent a 5 or 6-membered ring; where:n is independently an integer from 1 to 30; andR.sup.3 is independently a group selected from hydroxy, sulpho, cyano, --SR.sup.4, --CO.sub.2 R.sup.5, --PO.sub.3 H.sub.2 and --NR.sup.6 R.sup.7 ; where:R.sup.4, R.sup.5, R.sup.6 and R.sup.7 independently represent H, C.sub.1-30 alkyl optionally substituted by one or more groups selected from hydroxy, mercapto, sulpho, carboxy, cyano and --PO.sub.3 H.sub.2 ;v is the valence of Pc divided by the valence of M;x is from 1.2 to 3.8;y is from 0.1 to 2.7;z is from 0.1 to 2.7; andx, y and z satisfy 2.ltoreq.x+y+z.ltoreq.4.
    Type: Grant
    Filed: February 1, 1999
    Date of Patent: November 21, 2000
    Assignee: Zeneca Limited
    Inventors: Colin Dick Robertson, Mark Kenworthy
  • Patent number: 6150588
    Abstract: Antimicrobial proteins are isolated from seeds of Impatiens, and show a wide range of antifungal activity and some antibacterial activity. DNA encoding the proteins is isolated and incorporated into vectors. Plants transformed with this DNA are produced. The invention further provides a method of expressing polyproteins in transgenic plants using DNA constructs based on the structure of the gene encoding the Impatiens antimicrobial proteins.
    Type: Grant
    Filed: April 4, 1997
    Date of Patent: November 21, 2000
    Assignee: Zeneca Limited
    Inventors: Sheila Attenborough, Willem Frans Broekaert, Rupert William Osborn, John Anthony Ray, Sarah Bronwen Rees, Ravindra Haribhai Tailor
  • Patent number: 6149843
    Abstract: Microcapsules containing a biologically active material which is sensitive to ultraviolet light are prepared which contain an ultraviolet light protectant selected from titanium dioxide, zinc oxide and mixtures thereof, suspended and thoroughly dispersed in a liquid.
    Type: Grant
    Filed: July 22, 1998
    Date of Patent: November 21, 2000
    Assignee: Zeneca Limited
    Inventors: Herbert B. Scher, Jin Ling Chen
  • Patent number: 6146879
    Abstract: A method is presented for spray-drying whole microorganisms of Fusarium lateritium, Methylophilus methylotrophus, and Pseudomonas putida under conditions that the activity of cyanide hydratase, amidase and D-2-haloalkanoic acid halidohydrolase respectively are retained.
    Type: Grant
    Filed: November 12, 1997
    Date of Patent: November 14, 2000
    Assignee: Zeneca Limited
    Inventors: John Macdonald Liddell, William Greer
  • Patent number: RE36990
    Abstract: A method for the recovery of a metal from an organic complex thereof, said method comprising treating the complex with a weakly acid aqueous solution of an alkali metal, an alkaline earth metal or ammonium chloride having a chloride content of at least 4 molar whereby said complex is decomposed and metal ions are transferred to the aqueous solution.
    Type: Grant
    Filed: July 26, 1996
    Date of Patent: December 19, 2000
    Assignee: Zeneca Limited
    Inventors: Domenico C. Cupertino, Peter A. Tasker